Sutural growth depends on maintenance of a balance between proliferation of osteogenic stem cells and their differentiation to form new bone, so that the stem cell population is maintained until growth of the skull is complete. The identi®cation of heterozygous mutations in FGFR1, -2 and -3 and TWIST as well as microdeletions of TWIST in human craniosynostosis syndromes has highlighted these genes as playing important roles in maintaining the suture as a growth centre. In contrast to Drosophila, a molecular relationship between human (or other vertebrate) TWIST and FGFR genes has not yet been established. TWIST mutations exert their effect via haploinsuf®ciency whereas FGFR mutations have a gain-of-function mechanism of action. To investigate the biological basis of FGFR signalling pathways in the developing calvarium we compared the expression patterns of Twist with those of Fgfr1, -2 and -3 in the fetal mouse coronal suture over the course of embryonic days 14-18, as the suture is initiated and matures. Our results show that: (1) Twist expression precedes that of Fgfr genes at the time of initiation of the coronal suture; (2) in contrast to Fgfr transcripts, which are localised within and around the developing bone domains, Twist is expressed by the midsutural mesenchyme cells. Twist expression domains show some overlap with those of Fgfr2, which is expressed in the most immature (proliferating) osteogenic tissue. q
Introduction
The twist gene was originally identi®ed in Drosophila as one of the zygotic genes required for dorso-ventral patterning during embryogenesis; homozygous twist-null embryos fail to generate mesoderm (Nu Èsslein-Volhard et al., 1984) . The identi®cation of heterozygous mutations in FGFR1, -2 and -3 and TWIST as well as microdeletions of TWIST in human craniosynostosis syndromes (reviewed by Wilkie, 1997; Johnson et al., 1998) has highlighted these genes as playing important roles in maintaining the suture as a growth centre. Evidence that twist is upstream of Fgfr signalling during mesoderm formation in Drosophila comes from the observation that RNA expression of DFR1/htl (an orthologue of mammalian FGFRs) requires twist protein (Shishido et al., 1993) .
In cultured mouse calvarial osteoprogenitor cells, Twist expression is down-regulated during differentiation (Murray et al., 1992) , suggesting either that it promotes proliferation or that it inhibits differentiation, as in myogenesis (Hebrok et al., 1994) . Here we describe the expression pattern of Twist in the fetal mouse coronal suture and compare it with those of Fgfr1, -2 and -3 over the time course E14± E18, as the suture is initiated and matures.
Results
The mouse coronal suture is ®rst detected at E14. Initiation and maturation progresses from the region closest to the skull base towards the apex, so that in serial transverse sections, as studied here, there is always a greater degree of sutural maturity, including the amount of overlap of the frontal (inner) and parietal (outer) bone plates, in the more basal regions of the suture. 
E14 expression pattern (Fig. 1)
Twist is expressed throughout the developing subcutaneous tissue, and in the developing skeletogenic membrane, particularly the outer aspect of the future parietal bone domain. Close to the skull base the future coronal suture can be identi®ed as a fusiform swelling of the skeletogenic membrane composed of cells expressing Twist. A few cells deep to the endocranial layer (presumably dura mater cells) also show strong Twist expression speci®cally subjacent to the suture (Fig. 1A) . Fgfr2 and -3 show strong expression in the epidermis as well as the skeletogenic membrane. The midsutural mesenchyme can be seen to have a lower level of expression of Fgfr2 and -3 than the future bone domains, clearly demarcating the position of the future coronal suture; again this pattern was only apparent in the basal sections. Strong expression of Fgfr1 is detected throughout the skeletogenic membrane, but even in basal sections there is no clear distinction between future sutural and bone domains.
In sections taken from higher levels than those illustrated, i.e. closer to the vertex of the skull where differentiation is always less advanced than basally, Fgfr1 and Fgfr3 transcripts are undetectable but low levels of Fgfr2 transcripts are detected uniformly throughout the mesenchymal tissue that will later divide into skeletogenic and meningeal layers. Only Twist gives a strong signal speci®cally within the outer (skeletogenic) layer.
E16 expression pattern (Fig. 2)
Osteoid is now present in the differentiating regions of the frontal and parietal bones and the level of Twist expression in the midsutural mesenchyme is greater than that observed on the two preceding days. The Fgfr expression patterns at E15 (not shown) and E16 correspond to differentiating cells attached to the osteoid (Fgfr1), proliferating cells at the periphery of the bone plates (Fgfr2) and cells in an intermediate position (Fgfr3), as observed by Iseki et al. (1999) . Fgfr2-positive cells extend to form a fan-like shape around the sutural ends of the two bones, showing some overlap with the midsutural Twist domain. Comparison of Fgfr1 and Twist expression patterns suggests that their domains may be mutually exclusive.
At this stage, the endocranial layer of mesenchymal tissue (endocranium and meninges) that lies immediately subjacent to the skeletogenic membrane is composed of several layers of¯attened cells, in contrast to the more rounded cells of the midsutural mesenchyme. The endocranium is thicker beneath the coronal suture than beneath the areas of differentiating bone. (Fig. 3) The overall expression level of Twist in the skeletogenic membrane has decreased compared with previous days. At E17 (not shown) and E18 the Twist expression domain splits into two clearly de®ned zones as the increasing overlap of the frontal and parietal plates separates their sutural borders. The established positional relationship between the expression domains of Twist and the three Fgfr genes is retained.
E18 expression pattern

Experimental procedures
C57BL/6 mouse fetuses (plug day E0) were used. In situ hybridisation was carried out on 12-mm serial transverse frozen sections from fetal mouse heads taken at E14±E18 using 400 ng/ml of digoxygenin-labelled probes, as described previously (Iseki et al., 1997) . The following mouse probes were used for in situ hybridisation: (1) Twist ± a 420 bp fragment consisting of exon 2 (non-translated exon); (2) Fgfr1 ± a 3.8 kb fragment (IIIc splice variant); (3) Fgfr2 ± a 1.96 kb fragment including the whole extracellular and transmembrane domains (IIIc splice variant); (4) Fgfr3 ± full length (IIIc splice variant). All were cloned into pBluescript SK(1) (Stratagene). The Fgfr transcripts were reduced to an average size of 200 bases by limited alkaline hydrolysis.
